Results

1–10 of 29 results for proliferative diabetic retinopathy (PDR)

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial
Charles C. Wykoff, MD, PhD
Annual Meeting Talks
2019
Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)
Dennis M. Marcus, MD
Annual Meeting Talks
2019
PDR; High Myopia; PRP
Carissa Hurdstrom
Retina Image Bank: Images of the Week
Episode 151: Novel Understanding of Diabetic Retinopathy with Dr. Thomas Gardner
Jayanth Sridhar, MD
Member Podcasts
2018
Episode 119: 2018 ASRS Annual Meeting Post-Mortem Including Protocol S 5-Year Results
Jayanth Sridhar, MD
Member Podcasts
2018
Episode 22: Stroke Risk in Patients with CRAO with Dr. Matthew Schrag
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Episode 21: Eyes with PDR that were Lost to Followup after PRP or Anti-VEGF Treatment with Dr. Jason Hsu
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Ranibizumab Induces Regression of Diabetic Retinopathy
Charles C. Wykoff, MD, PhD
Updates from the Field
2016
New Data and Insights from Several DRCR.net Protocols
Lee Jampol, MD
Updates from the Field
2017